INDV Buybacks
5 quarter-specific issuer repurchase-cash observations normalized from SEC filings, newest first. A filed zero remains visible; a missing filing fact is never converted into zero. This page shows rows 1–5; provenance stays internal.
| Issuer profile | Period end | Type | Reported cash |
|---|---|---|---|
| Indivior Pharmaceuticals, Inc. | 2026-03-31 | Reported repurchase cash | $125M |
| Indivior Pharmaceuticals, Inc. | 2025-12-31 | Reported repurchase cash | $0.00 |
| Indivior Pharmaceuticals, Inc. | 2025-03-31 | Reported repurchase cash | $11M |
| Indivior Pharmaceuticals, Inc. | 2024-12-31 | Reported repurchase cash | $50M |
| Indivior Pharmaceuticals, Inc. | 2024-03-31 | Reported repurchase cash | $36M |